EMA Explains Process For Assessing Suitability Of Biomarkers With Concerned Medicines
Executive Summary
A new EU guideline outlines the steps that notified bodies can take to facilitate the European Medicines Agency’s assessment of the appropriateness of a companion diagnostic’s use with a drug.